Time spent in the open arm during the first time point of elevated plus maze before self admin
Tags: Behavior · Heroin · Elevated plus maze
Project: u01_peter_kalivas
3 loci · 3 genes with independent associations · 3 total associated genes
# | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
---|---|---|---|---|---|---|---|---|---|
1 | chr3 | 153329192 | 154718613 | 1 | 1 | 5.91e-08 | 5.71e-02 | 4.89e-01 | Slc35c2 |
2 | chr5 | 151116412 | 152307872 | 1 | 1 | 4.25e-08 | 3.20e-03 | 2.57e-01 | Emc1 |
3 | chr7 | 14449451 | 15768722 | 1 | 1 | 2.37e-08 | 4.91e-01 | 1.00e+00 | LOC102551633 |
Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 0 | 0 | 1.13 |
Adipose | alternative TSS | 0 | 0 | 1.17 |
Adipose | gene expression | 0 | 0 | 1.06 |
Adipose | isoform ratio | 0 | 0 | 1.09 |
Adipose | intron excision ratio | 0 | 0 | 1.04 |
Adipose | mRNA stability | 0 | 0 | 1.09 |
BLA | alternative polyA | 0 | 0 | 1.18 |
BLA | alternative TSS | 0 | 0 | 1.08 |
BLA | gene expression | 0 | 0 | 1.08 |
BLA | isoform ratio | 0 | 0 | 1.09 |
BLA | intron excision ratio | 0 | 0 | 1.03 |
BLA | mRNA stability | 0 | 0 | 1.12 |
Brain | alternative polyA | 0 | 0 | 1.12 |
Brain | alternative TSS | 0 | 0 | 1.12 |
Brain | gene expression | 0 | 0 | 1.09 |
Brain | isoform ratio | 0 | 0 | 1.09 |
Brain | intron excision ratio | 0 | 0 | 1.04 |
Brain | mRNA stability | 0 | 0 | 1.08 |
Eye | alternative polyA | 0 | 0 | 1.2 |
Eye | alternative TSS | 0 | 0 | 1.2 |
Eye | gene expression | 0 | 0 | 1.13 |
Eye | isoform ratio | 0 | 0 | 0.95 |
Eye | intron excision ratio | 0 | 0 | 1.15 |
Eye | mRNA stability | 0 | 0 | 1.25 |
IL | alternative polyA | 0 | 0 | 1.21 |
IL | alternative TSS | 0 | 0 | 1.01 |
IL | gene expression | 0 | 0 | 1.06 |
IL | isoform ratio | 0 | 0 | 1.13 |
IL | intron excision ratio | 0 | 0 | 0.95 |
IL | mRNA stability | 0 | 0 | 1.11 |
LHb | alternative polyA | 0 | 0 | 1.13 |
LHb | alternative TSS | 0 | 0 | 1.03 |
LHb | gene expression | 0 | 0 | 1.05 |
LHb | isoform ratio | 0 | 0 | 1.09 |
LHb | intron excision ratio | 0 | 0 | 0.89 |
LHb | mRNA stability | 0 | 0 | 1.1 |
Liver | alternative polyA | 0 | 0 | 1.09 |
Liver | alternative TSS | 0 | 0 | 1.04 |
Liver | gene expression | 0 | 0 | 1.09 |
Liver | isoform ratio | 0 | 0 | 1.03 |
Liver | intron excision ratio | 0 | 0 | 1.03 |
Liver | mRNA stability | 0 | 0 | 1.08 |
NAcc | alternative polyA | 1 | 0 | 1.15 |
NAcc | alternative TSS | 0 | 0 | 1.16 |
NAcc | gene expression | 0 | 0 | 1.08 |
NAcc | isoform ratio | 0 | 0 | 1.1 |
NAcc | intron excision ratio | 0 | 0 | 1.04 |
NAcc | mRNA stability | 0 | 0 | 1.1 |
OFC | alternative polyA | 0 | 0 | 1.27 |
OFC | alternative TSS | 0 | 0 | 1.16 |
OFC | gene expression | 0 | 0 | 1.03 |
OFC | isoform ratio | 0 | 0 | 1.13 |
OFC | intron excision ratio | 0 | 0 | 0.99 |
OFC | mRNA stability | 0 | 0 | 1.08 |
PL | alternative polyA | 0 | 0 | 1.18 |
PL | alternative TSS | 0 | 0 | 1.11 |
PL | gene expression | 0 | 0 | 1.08 |
PL | isoform ratio | 0 | 0 | 1.09 |
PL | intron excision ratio | 0 | 0 | 1.07 |
PL | mRNA stability | 0 | 0 | 1.13 |
pVTA | alternative polyA | 0 | 0 | 1.15 |
pVTA | alternative TSS | 0 | 0 | 1.18 |
pVTA | gene expression | 0 | 0 | 1.08 |
pVTA | isoform ratio | 0 | 0 | 1.1 |
pVTA | intron excision ratio | 1 | 0 | 1.04 |
pVTA | mRNA stability | 0 | 0 | 1.12 |
RMTg | alternative polyA | 1 | 0.2 | 1.17 |
RMTg | alternative TSS | 0 | 0 | 1.08 |
RMTg | gene expression | 0 | 0 | 1.08 |
RMTg | isoform ratio | 0 | 0 | 1.14 |
RMTg | intron excision ratio | 0 | 0 | 1.01 |
RMTg | mRNA stability | 0 | 0 | 1.06 |